)
United-Guardian (UG) investor relations material
United-Guardian Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 2026 net sales rose 54% YoY to $3.49M; net income increased 247% to $930,912 from $268,441.
9M net sales rose 25% to $9.48M and net income increased to $2,478,393 from $1,456,162; growth spanned pharmaceuticals, cosmetic ingredients and medical lubricants.
Financial highlights
Q3 operating income was $1,108,928 versus $215,072; 9M operating income was $2,505,502 versus $1,521,447.
Q3 net income was $930,912, or $0.20 per diluted share, versus $268,441, or $0.06; 9M net income was $2,478,393, or $0.54 per share, versus $1,456,162, or $0.32.
Operating expenses rose 4% in Q3 and 2% in 9M; R&D expense rose 4% and 6%, respectively.
Outlook and guidance
Expected FY 2026 effective tax rate is 21%; working capital is expected to support operating requirements for at least 12 months.
A personal care product is in late-stage development, with launch planned for early 2027.
Renacidin payer outreach and healthcare-professional awareness efforts are planned; two major PBMs added Renacidin to formularies effective June 1 and July 1, 2026.
- Q2 2026 net income up 16% on 10% sales growth, led by cosmetics, pharmaceuticals, and new deals.UG
Q2 2026 - Q1 2026 net income jumped 46% on 16% higher sales, boosted by product demand and settlement income.UG
Q1 2026 - Virtual annual meeting to elect directors, approve pay, and ratify auditor, with strong governance.UG
Proxy filing - Net sales and income fell, but pharmaceuticals and medical lubricants posted year-over-year growth.UG
Q4 2025 - Annual meeting to elect directors, approve executive pay, and ratify auditor, with strong governance.UG
Proxy Filing - Sales and earnings fell year-over-year, but pharma and lubricant sales showed growth.UG
Q2 2025 - Net income and sales rose on strong cosmetic demand; pharma sales to recover.UG
Q3 2024 - Net sales and income soared, driven by cosmetic ingredient demand and pharma recovery.UG
Q2 2024 - Sales and net income dropped sharply in Q1 2025, led by a 63% fall in cosmetic ingredient sales.UG
Q1 2025
Next United-Guardian earnings date
Next United-Guardian earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)